Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07592793

Community Gateway to Health Study

The goal of this study is to evaluate the impact of a multi-level intervention on cancer prevention and social determinants of health outcomes. This partnership between academic and community-based researchers aims to link community health centers and communities in ways that maximize both civic engagement and participation in cancer control care. The system-level intervention consists of two components: (1) provision of community health center systems-level tools for cancer screening (breast, cervical, colorectal) and tobacco cessation treatment gaps; and (2) digital access screening and navigation. These interventions will be delivered via usual care.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Harvard TH Chan School of Public Health, Boston, Massachusetts, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Study participants include community health center and community partner staff participating in surveys and interviews about the implementation of the intervention.

Inclusion criteria

  • Community health center staff or community partners
  • Age 18 or older

Exclusion criteria

  • Under 18

Patients will not be individually recruited for the study because the intervention is being offered as part of routine care.

Treatment and study plan

Tools and Training for Cancer Control

Behavioral

This system level intervention consists of two components: (1) provision of community health center systems-level tools for cancer screening (breast, cervical, colorectal) and tobacco cessation treatment gaps; and (2) digital access screening and navigation.

Enhancing Social Capital and Civic Engagement

Behavioral

This community level intervention consists of a patient referral from a community health center to a community organization focused on building social capital and civic engagement to test the impact of connecting clinical and community resources explicitly for patients.

Primary outcomes

  1. Patients Screened for Colorectal Cancer

    Time frame: change from baseline to end of intervention period, an average of 1 year

    % patients who are up to date on colorectal cancer screening from EMR

  2. Patients Screened for Breast Cancer

    Time frame: change from baseline to end of intervention period, an average of 1 year

    % patients who are up to date on breast cancer screening from EMR

  3. Patients Screened for Cervical Cancer

    Time frame: change from baseline to end of intervention period, an average of 1 year

    % patients who are up to date on cervical cancer screening from EMR

  4. Patients Offered Pharmacotherapy for Smoking Cessation

    Time frame: change from baseline to end of intervention period, an average of 1 year

    % patients offered pharmacotherapy from EMR

Secondary outcomes

  1. Acceptability of the intervention

    Time frame: Post intervention, 1 year follow up

    Self reported via staff survey

  2. Feasibility of the intervention

    Time frame: Post intervention, 1 year follow up

    Self-reported via staff survey

Sponsors and collaborators

Lead sponsor

Harvard School of Public Health (HSPH)

Other

Collaborators

  • Caring Health Center
  • Massachusetts League of Community Health Centers
  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
May 18, 2026
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.